Literature DB >> 25294437

Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation.

Kalindi Parikh1, Andrew Appis, Rami Doukky.   

Abstract

Cardiac risk assessment prior to kidney and liver transplantation is controversial. Given the paucity of available organs, selecting appropriate recipients with favorable short- and long-term cardiovascular risk profile is crucial. Using noninvasive cardiac imaging tools to guide cardiovascular risk assessment and management can also be challenging and controversial. In this article, we address the burden of coronary artery disease among kidney and liver transplant candidates and review the literature pertaining to the diagnostic accuracy and the prognostic value of noninvasive cardiac imaging techniques in this population.

Entities:  

Mesh:

Year:  2014        PMID: 25294437     DOI: 10.1007/s12350-014-9997-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  96 in total

1.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

Authors: 
Journal:  Am J Kidney Dis       Date:  2005-04       Impact factor: 8.860

2.  Coronary computer tomographic angiography for preoperative risk stratification in patients undergoing liver transplantation.

Authors:  Daniel Jodocy; Susanne Abbrederis; Ivo W Graziadei; Wolfgang Vogel; Otmar Pachinger; Gudrun M Feuchtner; Werner Jaschke; Guy Friedrich
Journal:  Eur J Radiol       Date:  2011-06-12       Impact factor: 3.528

3.  Value of myocardial perfusion imaging in renal transplant evaluation.

Authors:  Chong Ghee Chew; Steve Unger; Sepehr Shakib
Journal:  Nephrology (Carlton)       Date:  2013-05       Impact factor: 2.506

Review 4.  Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management.

Authors:  Javed Ehtisham; Mario Altieri; Ephrem Salamé; Eric Saloux; Isabelle Ollivier; Martial Hamon
Journal:  Liver Transpl       Date:  2010-05       Impact factor: 5.799

5.  Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.

Authors:  Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Sharmila Dorbala; David M Charytan; Ron Blankstein; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2012-10

6.  Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the CORE320 study.

Authors:  Carlos E Rochitte; Richard T George; Marcus Y Chen; Armin Arbab-Zadeh; Marc Dewey; Julie M Miller; Hiroyuki Niinuma; Kunihiro Yoshioka; Kakuya Kitagawa; Shiro Nakamori; Roger Laham; Andrea L Vavere; Rodrigo J Cerci; Vishal C Mehra; Cesar Nomura; Klaus F Kofoed; Masahiro Jinzaki; Sachio Kuribayashi; Albert de Roos; Michael Laule; Swee Yaw Tan; John Hoe; Narinder Paul; Frank J Rybicki; Jeffery A Brinker; Andrew E Arai; Christopher Cox; Melvin E Clouse; Marcelo F Di Carli; Joao A C Lima
Journal:  Eur Heart J       Date:  2013-11-19       Impact factor: 29.983

7.  Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.

Authors:  F K Port; R A Wolfe; E A Mauger; D P Berling; K Jiang
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

8.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

9.  Coronary calcifications and plaque characteristics in patients with end-stage renal disease: a computed tomographic study.

Authors:  Borut Jug; Jigar Kadakia; Mohit Gupta; Jenny Papazian; Arya Derakhshani; Sheri Koplik; Ronald P Karlsberg; Matthew J Budoff
Journal:  Coron Artery Dis       Date:  2013-09       Impact factor: 1.439

10.  Stress echocardiography for risk stratification in patients with end-stage renal disease undergoing renal transplantation.

Authors:  Cristina Tita; Vanji Karthikeyan; Alice Stroe; Gordon Jacobsen; Karthik Ananthasubramaniam
Journal:  J Am Soc Echocardiogr       Date:  2007-07-27       Impact factor: 5.251

View more
  14 in total

1.  Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.

Authors:  Wael AlJaroudi; Tania Campagnoli; Ibtihaj Fughhi; Marwan Wassouf; Amjad Ali; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2015-08-22       Impact factor: 5.952

2.  Screening for coronary artery disease in kidney transplant candidates.

Authors:  Dana V Rizk; Samy Riad; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2014-10-09       Impact factor: 5.952

Review 3.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

4.  The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation.

Authors:  Wael AlJaroudi; Chiedozie Anokwute; Ibtihaj Fughhi; Tania Campagnoli; Marwan Wassouf; Aviral Vij; Michael Kharouta; Andrew Appis; Amjad Ali; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2017-09-18       Impact factor: 5.952

Review 5.  Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review.

Authors:  Aviral Vij; Yasmeen Golzar; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2017-06-26       Impact factor: 5.952

6.  Stress SPECT Myocardial Perfusion Imaging in End-Stage Renal Disease.

Authors:  Yasmeen Golzar; Rami Doukky
Journal:  Curr Cardiovasc Imaging Rep       Date:  2017-03-18

7.  Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials.

Authors:  Maria Octavia Rangel; Raysa Morales Demori; Sarah T Voll; Marwan Wassouf; Rizcallah Dick; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2014-12-11       Impact factor: 5.952

8.  SPECT myocardial perfusion imaging in liver transplantation candidates.

Authors:  W Lane Duvall; Aditi Singhvi; Nidhi Tripathi; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2018-08-23       Impact factor: 5.952

9.  Impact of integrating heart rate response with perfusion imaging on the prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.

Authors:  Javier Gomez; Ibtihaj Fughhi; Tania Campagnoli; Amjad Ali; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2016-06-01       Impact factor: 5.952

10.  The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.

Authors:  Rami Doukky; Ibtihaj Fughhi; Tania Campagnoli; Marwan Wassouf; Amjad Ali
Journal:  J Nucl Cardiol       Date:  2015-11-18       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.